WT1 and neoplasm: These data also suggested that, although as noted above, alterations in immunohistochemically detected p53 nuclear expression are associated with invasive tumours, these alterations in p53 expression are often associated with changes in WT1 expression in lethal type 2 tumours (see below and Fig. 2).